» Articles » PMID: 24583975

The Structure of the Infectious Prion Protein: Experimental Data and Molecular Models

Overview
Journal Prion
Specialty Biochemistry
Date 2014 Mar 4
PMID 24583975
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The structures of the infectious prion protein, PrP(Sc), and that of its proteolytically truncated variant, PrP 27-30, have evaded experimental determination due to their insolubility and propensity to aggregate. Molecular modeling has been used to fill this void and to predict their structures, but various modeling approaches have produced significantly different models. The disagreement between the different modeling solutions indicates the limitations of this method. Over the years, in absence of a three-dimensional (3D) structure, a variety of experimental techniques have been used to gain insights into the structure of this biologically, medically, and agriculturally important isoform. Here, we present an overview of experimental results that were published in recent years, and which provided new insights into the molecular architecture of PrP(Sc) and PrP 27-30. Furthermore, we evaluate all published models in light of these recent, experimental data, and come to the conclusion that none of the models can accommodate all of the experimental constraints. Moreover, this conclusion constitutes an open invitation for renewed efforts to model the structure of PrP(Sc).

Citing Articles

Characterization of variably protease-sensitive prionopathy by capillary electrophoresis.

Myskiw J, Bailey-Elkin B, Avery K, Barria M, Ritchie D, Cohen M Sci Rep. 2024; 14(1):27867.

PMID: 39537719 PMC: 11561330. DOI: 10.1038/s41598-024-79217-1.


Biological function of sialic acid and sialylation in human health and disease.

Zhu W, Zhou Y, Guo L, Feng S Cell Death Discov. 2024; 10(1):415.

PMID: 39349440 PMC: 11442784. DOI: 10.1038/s41420-024-02180-3.


Prion protein E219K polymorphism: from the discovery of the KANNO blood group to interventions for human prion disease.

Wang S, Meng Z, Zhang Y, Yan Y, Li L Front Neurol. 2024; 15:1392984.

PMID: 39050130 PMC: 11266091. DOI: 10.3389/fneur.2024.1392984.


Exploring a diverse world of effector domains and amyloid signaling motifs in fungal NLR proteins.

Wojciechowski J, Tekoglu E, Gasior-Glogowska M, Coustou V, Szulc N, Szefczyk M PLoS Comput Biol. 2022; 18(12):e1010787.

PMID: 36542665 PMC: 9815663. DOI: 10.1371/journal.pcbi.1010787.


Prion protein with a mutant N-terminal octarepeat region undergoes cobalamin-dependent assembly into high-molecular weight complexes.

Daude N, Lau A, Vanni I, Kang S, Castle A, Wohlgemuth S J Biol Chem. 2022; 298(4):101770.

PMID: 35271850 PMC: 9010764. DOI: 10.1016/j.jbc.2022.101770.


References
1.
Wille H, Prusiner S, Cohen F . Scrapie infectivity is independent of amyloid staining properties of the N-terminally truncated prion protein. J Struct Biol. 2000; 130(2-3):323-38. DOI: 10.1006/jsbi.2000.4242. View

2.
Safar J, Wille H, Itri V, Groth D, Serban H, Torchia M . Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med. 1998; 4(10):1157-65. DOI: 10.1038/2654. View

3.
Kocisko D, Lansbury Jr P, Caughey B . Partial unfolding and refolding of scrapie-associated prion protein: evidence for a critical 16-kDa C-terminal domain. Biochemistry. 1996; 35(41):13434-42. DOI: 10.1021/bi9610562. View

4.
Caughey B, Dong A, Bhat K, Ernst D, Hayes S, Caughey W . Secondary structure analysis of the scrapie-associated protein PrP 27-30 in water by infrared spectroscopy. Biochemistry. 1991; 30(31):7672-80. DOI: 10.1021/bi00245a003. View

5.
Kunes K, Clark S, Cox D, Singh R . Left handed beta helix models for mammalian prion fibrils. Prion. 2008; 2(2):81-90. PMC: 2634523. DOI: 10.4161/pri.2.2.7059. View